Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × Tetanus × Clear all

Phase

Status

Completed 4 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 827 Neoplasms 718 Carcinoma, Non-Small-Cell Lung 688 Prostatic Neoplasms 449 Leukemia, Myeloid, Acute 421 Neoplasm Metastasis 416 Melanoma 368 Multiple Myeloma 362 Colorectal Neoplasms 359 Lung Neoplasms 346 Pancreatic Neoplasms 299 Lymphoma 294 Recurrence 291 Ovarian Neoplasms 280 Leukemia 278 Lymphoma, Non-Hodgkin 277 Leukemia, Lymphocytic, Chronic, B-Cell 255 Precursor Cell Lymphoblastic Leukemia-Lymphoma 234 Carcinoma, Renal Cell 209 Brain Neoplasms 208 Head and Neck Neoplasms 198 Myelodysplastic Syndromes 196 Carcinoma, Hepatocellular 196 Lymphoma, Large B-Cell, Diffuse 191 Glioblastoma 188 Lymphoma, Follicular 185 Squamous Cell Carcinoma of Head and Neck 183 Colonic Neoplasms 150 Stomach Neoplasms 143 Rectal Neoplasms 143

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡